SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.74+0.1%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Judy who wrote (4271)7/12/1998 9:02:00 PM
From: Nancy  Read Replies (1) of 9523
 
Hi there, thanks for the information. I believe IMNX has filed for fast track approval for Enbrel.
Need to verify that and if otherwise will post.

PFE's Celebral has not filed for anything yet, schedule is in 1999. The thing confuses me is PFE said Celebral will be effective in BOTH RA and OsteoA treatment, and would be first of its kind.

Looks like Enbrel has a headstart here. Doesn't matter to me, I have both, just want to know more about both.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext